Market Place
Sourcing Support
All News #Library
Biotech
Blackstone & Anthos Announce Novartis has Completed Acquisition
03 Apr 2025 //
BUSINESSWIRE
Anthos Therapeutics Shares New Data from AZALEA-TIMI 71 Study
29 Mar 2025 //
GLOBENEWSWIRE
Abelacimab Cuts Bleeding By 62% Vs Xarelto In Atrial Fibrillation
22 Jan 2025 //
GLOBENEWSWIRE
Anthos Therapeutics Shares New AZALEA-TIMI 71 Study Analysis
16 Nov 2024 //
GLOBENEWSWIRE
Anthos: ~84% Eligible Patients Transitioned To Abelacimab In AZALEA Extension
06 Jun 2024 //
GLOBENEWSWIRE
Abelacimab`s cost-effectiveness analysis shows potential cost savings
06 May 2024 //
BUSINESSWIRE
Weeks after closing BMS deal, Karuna`s ex-CEO heads to Blackstone-backed Anthos
22 Apr 2024 //
ENDPTS
Anthos` Abelacimab, Demonstrated a 67% Reduction in Non-Major Bleeding
13 Nov 2023 //
BUSINESSWIRE
Study Confirming Reduction in Bleeding of Factor XI/XIa Inhibitor Abelacimab
26 Sep 2023 //
BUSINESSWIRE
First Patient Enrolled in Phase 3 Trial Evaluating Abelacimab
03 Jan 2023 //
GLOBENEWSWIRE
Lonza partners with Anthos Therapeutics for thrombosis treatment
11 Jun 2020 //
REUTERS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.